InvestorsHub Logo
Post# of 4974641
Next 10
Followers 21
Posts 1120
Boards Moderated 0
Alias Born 08/25/2006

Re: None

Thursday, 12/07/2006 10:46:01 AM

Thursday, December 07, 2006 10:46:01 AM

Post# of 4974641
EPIX- developing treatment to lower blood pressure.

"Discovered and designed using its PREDICT(TM) proprietary G-protein coupled receptor (GPCR) modeling and optimization technology, EPIX is developing PRX-08066 to provide both symptomatic improvement - through selective dilation of diseased pulmonary blood vessels - and to also slow disease progression - by inhibiting the thickening of the pulmonary artery vessels. EPIX believes PRX-08066 is the first 5-HT2B selective antagonist under development for pulmonary hypertension (PH) associated with chronic obstructive pulmonary disease (COPD)."

.
He who loves money will not be satisfied with money, nor he who loves abundance with its income. This too is vanity.
-Eccl 5:10

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.